HHM Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.3K Hold
175
﹤0.01% 447
2026
Q1
$29.5K Hold
175
﹤0.01% 447
2025
Q4
$29.5K Sell
175
-50
-22% -$8.12K ﹤0.01% 435
2025
Q3
$32.5K Hold
225
﹤0.01% 440
2025
Q2
$28.5K Hold
225
﹤0.01% 458
2025
Q1
$28.8K Hold
225
﹤0.01% 455
2024
Q4
$29.7K Buy
225
+150
+200% +$21.1K ﹤0.01% 436
2024
Q3
$10.9K Sell
75
-42
-36% -$6.08K ﹤0.01% 545
2024
Q2
$16.1K Buy
117
+12
+11% +$1.6K ﹤0.01% 488
2024
Q1
$14.4K Hold
105
﹤0.01% 467
2023
Q4
$14.3K Hold
105
﹤0.01% 458
2023
Q3
$12.8K Hold
105
﹤0.01% 467
2023
Q2
$13.3K Hold
105
﹤0.01% 479
2023
Q1
$13.6K Hold
105
﹤0.01% 471
2022
Q4
$13.8K Hold
105
﹤0.01% 408
2022
Q3
$12K Hold
105
﹤0.01% 411
2022
Q2
$12K Hold
105
﹤0.01% 502
2022
Q1
$14K Hold
105
﹤0.01% 499
2021
Q4
$16K Hold
105
﹤0.01% 456
2021
Q3
$17K Hold
105
﹤0.01% 428
2021
Q2
$17K Hold
105
﹤0.01% 417
2021
Q1
$16K Hold
105
﹤0.01% 403
2020
Q4
$16K Hold
105
0.01% 377
2020
Q3
$14K Hold
105
0.01% 354
2020
Q2
$14K Hold
105
0.01% 344
2020
Q1
$11K Buy
+105
New +$12.1K 0.01% 348

Other funds holding IBB

HHM Wealth Advisors's IBB Position: Q2 2026 in Review

HHM Wealth Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 175 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #447.

HHM Wealth Advisors first reported a position in IBB in Q1 2020 and has held it in 26 quarters since. 320 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • HHM Wealth Advisors held 175 shares of iShares Biotechnology ETF worth $33.3K as of Q2 2026.
  • HHM Wealth Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #447 holding.
  • HHM Wealth Advisors first reported a position in iShares Biotechnology ETF in Q1 2020 and has held it in 26 quarters since.
  • 320 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.